Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

SINGAPORE, SG / ACCESS Newswire / November 25, 2025 / Dr. Byung Joon Han, co-founder and CEO of Silicon Box attended the Bloomberg New Economy Forum (NEF) 2025, joining leaders from across 50 ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...

DIY Christmas tree and gift box in one. Handmade festive decoration project. Michigan Couple Faces Major Charges Over Undocumented Workers Man who rushed Ariana Grande at "Wicked: For Good" premiere ...

On Tuesday, Merck & Co. Inc. (NYSE:MRK) and Eisai shared topline data from the Phase 3 LITESPARK-011 trial of the dual oral regimen of Welireg (belzutifan) plus Lenvima (lenvatinib). The trial met one ...

Merck (NYSE:MRK) and Eisai (OTCPK:ESALF) Tuesday said that their Phase 3 LITESPARK-011 trial met a key goal, showing improved progression-free survival for patients with advanced kidney cancer treated ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients whose prostate cancer had returned, a large international clinical trial has ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...

The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in hepatocellular carcinoma patients. Median progression-free survival was 8.3 months with ...

Breakthrough yield and device performance at high volume show team can scale company's large-format advanced packaging for customers' cutting-edge applications SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- ...

Breakthrough yield and device performance at high volume show team can scale company’s large-format advanced packaging for customers’ cutting-edge applications SINGAPORE, SG / ACCESS Newswire / ...

CEO Aaron Levie reported "a strong second quarter with results above our guidance, reflecting continued growth in customer adoption of Box AI and our advanced workflow capabilities." He highlighted ...